Company Monitoring Page for Genentech

latest headlines for company on cafepharma

Pfizer Calls for FDA Guidance to Address False and Misleading Biosimilar Ads
RAPS.org
Tue, 08/28/18 - 08:00 pm
Tags:
Pfizer, FDA, biosimilars, Amgen, Genentech, drug ads
Affimed and Roche ink $5bn plus cancer immunotherapy deal
Pharmaforum
Tue, 08/28/18 - 10:03 am
Tags:
Roche, Genentech, Affimed, cancer immunotherapy, drug development
As biosimilars loom, Roche's Genentech plans to lay off 223 staffers in California
Fierce Pharma
Wed, 08/15/18 - 10:28 pm
Tags:
Roche, Genentech, WARN notice, layoffs, California
Genentech, Horizon Earn Spots on List of ‘Companies That Care’
BioSpace
Sat, 07/28/18 - 12:39 pm
Tags:
Genentech, Horizon Pharma, employees
Roche vaults into lead in frontline triple negative breast cancer as Tecentriq/Abraxane combo aces progression-free survival
Endpoints
Mon, 07/2/18 - 09:37 am
Tags:
Roche, Tecentriq, Genentech, triple negative breast cancer, Celgene, Abraxane
Microbiome report for week ending 6-24-18
CP Wire
Wed, 06/27/18 - 07:53 pm
Tags:
Axial Biotherapeutics, Kallyope, Novo Nordisk, CosmosID, microbiome, precisionFDA, Janssen, Microbiotica, Genentech
Wed, 06/27/18 - 07:51 pm
Tags:
Axial Biotherapeutics, Kallyope, Novo Nordisk, CosmosID, microbiome, precisionFDA, Janssen, Microbiotica, Genentech
FDA Approves Genentech’s Rituxan For Rare Autoimmune Disease Pemphigus Vulgaris
CP Wire
Fri, 06/8/18 - 10:07 am
Tags:
Genentech, Rituxan, FDA, pemphigus vulgaris, Genentech/Roche
Genentech signs $534M deal with Microbiotica to search gut bacteria for IBD targets, new drugs
Fierce Biotech
Wed, 06/6/18 - 10:30 am
Tags:
Genentech, Microbiotica, microbiome, IBD, biomarkers
Roche Up, J&J Down as Cancer Drug Combos Yield More Mixed Results
Xconomy
Tue, 05/29/18 - 11:36 am
Tags:
clinical trials, Roche, Genentech, Genmab, JNJ, cancer, Tecentriq, Darzalex
Genentech allies with a metagenomics upstart in New York on a discovery deal jam packed with biobucks
Endpoints
Wed, 05/9/18 - 09:27 pm
Tags:
Genentech, Roch, New York, Lodo Therapeutics, microbial DNA
FDA promises Roche a snap decision on Tecentriq triple for frontline lung cancer as it falls even further behind Merck, Bristol-Myers
Endpoints
Mon, 05/7/18 - 09:50 am
Tags:
Roche, Tecentriq, FDA, Genentech, lung cancer
Genentech antibody spotlights new target for antibiotic-resistant bacteria
Fierce Biotech
Sat, 03/24/18 - 09:09 am
Tags:
Genentech, antibiotic resistance, antibiotics, R&D, drug discovery, BamA enzyme
After FDA setback, Bellicum bolsters R&D team with ex-Genentech executive
Fierce Biotech
Tue, 02/6/18 - 09:51 am
Tags:
FDA, Bellicum, R&D, Genentech
[forum discussion]Over 50
Cafepharma Message Boards
Tue, 01/23/18 - 04:39 pm
Tags:
Genentech
Genentech beefs up its PD-L1 combo pipeline, signing the ‘don’t eat me’ specialists at Forty Seven
Endpoints
Sat, 01/13/18 - 02:01 pm
Tags:
Genentech, anti-PD-1 immunotherapy, Forty Seven
Roche Gains Ground on Rivals With Drug Combo’s Success in Lung Cancer
Xconomy
Mon, 11/20/17 - 09:40 am
Tags:
Roche, lung cancer, Genentech, Tecentriq
FDA Approves Genentech Hemophilia Drug, But Adds Safety Warning
Xconomy
Fri, 11/17/17 - 10:19 am
Tags:
Genentech, FDA, hemophilia A, Hemlibra
Genentech inks $650M deal with protein degradation pioneer Arvinas
Endpoints
Wed, 11/15/17 - 11:10 am
Tags:
Genentech, targeted protein degradation, Arvinas, R&D
Last week in pharma.bio.device.lab November 5-11 2017
CP Wire
Sun, 11/12/17 - 02:24 pm
Tags:
layoffs, Eli Lilly, Genentech, Amgen, Valeant Pharmaceuticals, Addyi, FDA, Scott Gottlieb, physician payments

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.